BERKELEY'S NEWS • SEPTEMBER 26, 2022

tag

Broad Institute of MIT and Harvard

Page 1 of 1

The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
featured article
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
featured article
Researchers at UC Berkley and UCSF published new findings about gene-modifying proteins in December connected to their research of CRISPR technology, a natural bacterial defense mechanism that is the subject of an ongoing patent dispute.
featured article
Researchers at UC Berkley and UCSF published new findings about gene-modifying proteins in December connected to their research of CRISPR technology, a natural bacterial defense mechanism that is the subject of an ongoing patent dispute.
featured article
The U.S. Patent and Trademark Office issued Caribou Biosciences, a startup co-founded by UC Berkeley researcher Jennifer Doudna, intellectual property rights for developments in CRISPR gene-editing technology Tuesday.
featured article
The U.S. Patent and Trademark Office issued Caribou Biosciences, a startup co-founded by UC Berkeley researcher Jennifer Doudna, intellectual property rights for developments in CRISPR gene-editing technology Tuesday.
featured article